Free tool
FAERS Monitor: Technescan Hdp
Last checked: Nov 20, 2026FDA FAERS (openFDA) last updated: Oct 28, 2026Methods & limitations
Reports naming NDA 018321 or its brand name (Technescan Hdp, Technetium Tc-99m Oxidronate Kit). Reports on generic versions are filed under their own applications.
Reports
136
Serious
68
50% of reports
Hospitalization
18
Death reported
3
Any cause; not necessarily from the drug
Most reported reactions
MedDRA preferred terms.
- nausea16
- bone scan abnormal14
- injection site pain10
- drug ineffective9
- headache9
- injection site swelling8
- injection site erythema7
- injection site extravasation7
- dizziness6
- product administration error6
- product preparation issue6
- radioisotope scan abnormal6
- vomiting6
- chest pain5
- dysgeusia5
Reports by year received
View as table
| Year | Reports |
|---|---|
| 2004 | 4 |
| 2005 | 2 |
| 2007 | 1 |
| 2010 | 1 |
| 2012 | 2 |
| 2013 | 3 |
| 2014 | 5 |
| 2015 | 1 |
| 2016 | 3 |
| 2017 | 2 |
| 2018 | 11 |
| 2019 | 7 |
| 2020 | 11 |
| 2021 | 66 |
| 2022 | 1 |
| 2023 | 3 |
| 2024 | 5 |
| 2025 | 5 |
| 2026 | 3 |
Disproportionality screen
Proportional reporting ratio (PRR): how much more often each reaction appears in this drug's reports than in the other 21,054,023 FAERS reports. Flagged when PRR is at least 2, chi-squared at least 4 and there are 3 or more reports (Evans criteria). A screening statistic only.
| Reaction | Reports | PRR | 95% CI lower | Chi-squared |
|---|---|---|---|---|
| bone scan abnormalSignal | 14 | 5273.3 | 3181.0 | 66,361 |
| radioisotope scan abnormalSignal | 6 | 1325.0 | 603.9 | 6,613 |
| product preparation issueSignal | 6 | 141.6 | 64.7 | 702 |
| injection site extravasationSignal | 7 | 87.8 | 42.7 | 517 |
| product administration errorSignal | 6 | 45.9 | 21.0 | 221 |
| injection site swellingSignal | 8 | 16.1 | 8.2 | 99 |
| dysgeusiaSignal | 5 | 10.4 | 4.4 | 34 |
| injection site erythemaSignal | 7 | 8.7 | 4.2 | 41 |
| injection site painSignal | 10 | 5.0 | 2.8 | 29 |
| chest painSignal | 5 | 4.2 | 1.8 | 9 |
| nauseaSignal | 16 | 3.1 | 2.0 | 22 |
| headacheSignal | 9 | 2.2 | 1.2 | 5 |
| vomiting | 6 | 2.0 | 0.9 | 2 |
| dizziness | 6 | 1.9 | 0.9 | 2 |
| drug ineffective | 9 | 1.1 | 0.6 | 0 |
A high PRR for a reaction that is also the condition being treated (for example "disease progression" for a cancer drug) is expected and is not a safety signal.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.